ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Franklin BSP Realty Trust, Inc. Investors to Inquire About Securities Class Action Investigation – FBRT

New York, New York–(Newsfile Corp. – February 25, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) resulting from allegations that Franklin BSP Realty Trust, Inc. may have issued materially misleading business information […]

TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering

(NasdaqGM:TRGSU),(NasdaqGM:TRGS),(NasdaqGM:TRGSR), NEW YORK, NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) — TRG Latin America Acquisitions Corp. (“TRG” or the “Company”) announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Stock Exchange (“Nasdaq”) and trade under the ticker symbol “TRGSU” beginning

TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering

TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering GlobeNewswire February 26, 2026 NEW YORK, NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) — TRG Latin America Acquisitions Corp. (“TRG” or the “Company”) announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units will

ROSEN, A LONGSTANDING LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTGN

New York, New York–(Newsfile Corp. – February 25, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the “Class Period”), of the important March 16, 2026 lead plaintiff deadline. SO WHAT:

Enerflex Ltd. Announces Fourth Quarter 2025 Financial and Operational Results, Agreement to Divest Non-Core Business and Provides Preliminary Outlook for 2026

(TSX:EFX),(NYSE:EFXT), ADJUSTED EBITDA OF $123 MILLION AND RECORD FREE CASH FLOW OF $141 MILLIONREDUCED NET DEBT TO $501 MILLION OR APPROXIMATELY 1.0x TTM ADJUSTED EBITDA AT THE END OF Q4/25STRONG OPERATIONAL VISIBILITY WITH ES AND EI BACKLOG OF $1.1 BILLION AND $1.3 BILLION, RESPECTIVELYSIGNED AN AGREEMENT TO DIVEST OPERATIONS IN ASIA PACIFIC REGION, CONTINUING EFFORTS

INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RARE

San Diego, California–(Newsfile Corp. – February 25, 2026) – The law firm of Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between August 3, 2023 and December 26, 2025, inclusive (the “Class Period”), have until Monday, April 6, 2026 to seek appointment as lead plaintiff

Enerflex Ltd. Announces Fourth Quarter 2025 Financial and Operational Results, Agreement to Divest Non-Core Business and Provides Preliminary Outlook for 2026

Enerflex Ltd. Announces Fourth Quarter 2025 Financial and Operational Results, Agreement to Divest Non-Core Business and Provides Preliminary Outlook for 2026 GlobeNewswire February 26, 2026 ADJUSTED EBITDA OF $123 MILLION AND RECORD FREE CASH FLOW OF $141 MILLIONREDUCED NET DEBT TO $501 MILLION OR APPROXIMATELY 1.0x TTM ADJUSTED EBITDA AT THE END OF Q4/25STRONG OPERATIONAL

Castlebar Capital Corp. Announces Closing of Non-Brokered Private Placement

Vancouver, British Columbia–(Newsfile Corp. – February 25, 2026) – Castlebar Capital Corp. (TSXV: CBAR.P) (the “Company” or “Castlebar“), a capital pool company listed on the TSX Venture Exchange (the “TSXV“), is pleased to announce that it has closed its non-brokered private placement of 1,500,000 common shares (the “Shares“) at a price of $0.10 per Common

DNOW Investor News: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation – DNOW

New York, New York–(Newsfile Corp. – February 25, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of DNOW Inc. (NYSE: DNOW) resulting from allegations that DNOW Inc. may have issued materially misleading business information to the investing public. SO WHAT:

Considering MEDVi Tirzepatide GLP-1 Weight Loss in 2026? Read This Before Enrolling in Any Tirzepatide GLP-1 Telehealth Weight Loss Program

NEWARK, DE, Feb. 25, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Compounded medications are not FDA-approved finished products. Consult a licensed healthcare provider before starting any weight loss program or medication. If you purchase through links in this article, a

Scroll to Top